Integrated Cancer Care Services

Investment Amount: $4,300,000
Investment Date: December, 2018


CapX stepped up equipment finance funding for this healthcare client in 2018 when its client development strategy ramped up.

This medical technology company employs a non-invasive, revolutionary treatment comfortably delivered in a dermatologist’s office to non-invasively and curatively treat non-melanoma skin cancers. After scaling in $5M of funding through the first 9 months of 2018, CapX added another $4.3M equipment lease to their total 2018 financing commitment.